Results 251 to 260 of about 693,900 (279)

Advances in PARP Inhibitors for Prostate Cancer

Cancers, 2023
Tamim Niazi, Maurice Anidjar
exaly  

Haematologic toxicities with PARP inhibitors in cancer patients: an up‑to‑date meta‑analysis of 29 randomized controlled trials

Journal of Clinical Pharmacy and Therapeutics, 2021

exaly  

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Johann S de Bono, Timothy A Yap, Shahneen Sandhu   +2 more
exaly  

PARP Inhibitors

2014
Joaquin Mateo, Timothy A. Yap, Johann S. De Bono   +2 more
openaire   +1 more source

PARP and PARP Inhibitor Therapeutics

2013
openaire   +1 more source

PARP inhibitors in ovarian cancer

Cancer Treatment Reviews, 2019
Michele Orditura, Fortunato Ciardiello, Sandro Pignata   +2 more
exaly  

PARP inhibitors: Clinical utility and possibilities of overcoming resistance

Gynecologic Oncology, 2017
Zachary Watson, Benjamin Bitler, Kian Behbakht   +2 more
exaly  

Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy

Cancer Cell, 2019
Ken Chen, Zhenlin Ju, Gordon Mills
exaly  

Elevated CXorf67 Expression in PFA Ependymomas Suppresses DNA Repair and Sensitizes to PARP Inhibitors

Cancer Cell, 2020
Meng Yu, Lin Li, Chen Li
exaly  

The forefront of ovarian cancer therapy: update on PARP inhibitors

Annals of Oncology, 2020
Kathleen Moore, Nicoletta Colombo, R L Coleman   +2 more
exaly